Clinical Trial Update: LEAn Body Mass Normalization of OXaliplatin Based Chemotherapy [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating lean body mass–adjusted dosing of oxaliplatin-based chemotherapy in Stage III colon cancer, with active but not recruiting statu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colon Cancer

Drugs mentioned

• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: Institut du Cancer de Montpellier - Val d'Aurelle | Conditions: Stage III Colon Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING